Status:
COMPLETED
Treatment Frequency and Satisfaction in Patients With Advanced Prostate Cancer
Lead Sponsor:
Copenhagen University Hospital at Herlev
Conditions:
Prostatic Neoplasms
Eligibility:
MALE
18+ years
Brief Summary
Patients with advanced prostate cancer usually receive some kind of pharmaceutical castration or undergo surgical castration. At the investigators department the pharmaceutical treatment is most often...
Eligibility Criteria
Inclusion
- A diagnosis of advanced prostate cancer
- Receiving hormone manipulation treatment (pharmaceutical castration) OR having undergone surgical castration (orchiectomy)
Exclusion
- Inability to read/write Danish
Key Trial Info
Start Date :
September 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
178 Patients enrolled
Trial Details
Trial ID
NCT01441713
Start Date
September 1 2011
End Date
June 1 2012
Last Update
December 5 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of urology, Herlev Hospital
Herlev, Denmark, 2730